JPY 1281.0
(0.71%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 23.17 Billion JPY | -0.66% |
2022 | 21.26 Billion JPY | -9.44% |
2021 | 25.09 Billion JPY | 30.37% |
2020 | 16.51 Billion JPY | -46.99% |
2019 | 37.27 Billion JPY | -17.06% |
2018 | 23.25 Billion JPY | 0.46% |
2017 | 45.11 Billion JPY | 32.26% |
2016 | 31.22 Billion JPY | 14.51% |
2015 | 30.11 Billion JPY | 11.97% |
2014 | 21 Billion JPY | 5.43% |
2013 | 21.15 Billion JPY | 16.94% |
2012 | 21.67 Billion JPY | -44.18% |
2011 | 16.75 Billion JPY | 2.14% |
2010 | 17.23 Billion JPY | 3.65% |
2009 | 13.56 Billion JPY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 6.05 Billion JPY | 28.86% |
2024 Q1 | 3.34 Billion JPY | 80.82% |
2023 Q3 | 3.47 Billion JPY | -47.22% |
2023 Q4 | 6.23 Billion JPY | 79.44% |
2023 FY | - JPY | -0.66% |
2023 Q1 | 4.85 Billion JPY | 75.11% |
2023 Q2 | 6.58 Billion JPY | 35.56% |
2022 FY | - JPY | -9.44% |
2022 Q4 | 2.77 Billion JPY | -16.58% |
2022 Q3 | 3.32 Billion JPY | -31.33% |
2022 Q2 | 4.83 Billion JPY | 16.38% |
2022 Q1 | 4.15 Billion JPY | -24.95% |
2021 Q1 | 5.78 Billion JPY | 19.87% |
2021 Q3 | 2.98 Billion JPY | -37.22% |
2021 FY | - JPY | 30.37% |
2021 Q4 | 5.54 Billion JPY | 85.78% |
2021 Q2 | 4.75 Billion JPY | -17.89% |
2020 Q2 | 4.58 Billion JPY | 1160.71% |
2020 FY | - JPY | -46.99% |
2020 Q3 | 3.25 Billion JPY | -29.07% |
2020 Q4 | 4.82 Billion JPY | 48.26% |
2020 Q1 | 364 Million JPY | -94.11% |
2019 Q2 | 9.03 Billion JPY | 32.65% |
2019 Q4 | 6.18 Billion JPY | -30.29% |
2019 Q3 | 8.87 Billion JPY | -1.79% |
2019 FY | - JPY | -17.06% |
2019 Q1 | 6.8 Billion JPY | 0.43% |
2018 Q1 | 9.47 Billion JPY | 11.8% |
2018 FY | - JPY | 0.46% |
2018 Q4 | 6.78 Billion JPY | -28.47% |
2018 Q3 | 9.47 Billion JPY | -28.61% |
2018 Q2 | 13.27 Billion JPY | 40.11% |
2017 FY | - JPY | 32.26% |
2017 Q1 | 8.97 Billion JPY | -7.96% |
2017 Q2 | 12 Billion JPY | 33.75% |
2017 Q3 | 9.86 Billion JPY | -17.88% |
2017 Q4 | 8.47 Billion JPY | -14.05% |
2016 Q4 | 9.75 Billion JPY | 56.84% |
2016 Q1 | 3.39 Billion JPY | -51.66% |
2016 Q2 | 7.89 Billion JPY | 132.28% |
2016 Q3 | 6.21 Billion JPY | -21.21% |
2016 FY | - JPY | 14.51% |
2015 Q2 | 6.64 Billion JPY | 84.02% |
2015 FY | - JPY | 11.97% |
2015 Q4 | 7.03 Billion JPY | 22.28% |
2015 Q1 | 3.61 Billion JPY | -56.2% |
2015 Q3 | 5.74 Billion JPY | -13.48% |
2014 Q1 | 5.19 Billion JPY | -25.99% |
2014 FY | - JPY | 5.43% |
2014 Q3 | 2.88 Billion JPY | -1.3% |
2014 Q4 | 8.24 Billion JPY | 185.95% |
2014 Q2 | 2.92 Billion JPY | -43.75% |
2013 FY | - JPY | 16.94% |
2013 Q4 | 7.01 Billion JPY | 98.0% |
2013 Q3 | 3.54 Billion JPY | -31.94% |
2013 Q1 | 2.16 Billion JPY | 110.52% |
2013 Q2 | 5.2 Billion JPY | 141.06% |
2012 Q1 | 10.03 Billion JPY | 251.0% |
2012 Q3 | 11.73 Billion JPY | -12.57% |
2012 Q4 | -20.52 Billion JPY | -274.83% |
2012 Q2 | 13.42 Billion JPY | 33.79% |
2012 FY | - JPY | -44.18% |
2011 Q2 | 13.54 Billion JPY | 33.65% |
2011 Q4 | 2.85 Billion JPY | -77.7% |
2011 FY | - JPY | 2.14% |
2011 Q1 | 10.13 Billion JPY | 234.71% |
2011 Q3 | 12.81 Billion JPY | -5.36% |
2010 Q4 | 3.02 Billion JPY | -75.57% |
2010 Q3 | 12.39 Billion JPY | 3.7% |
2010 FY | - JPY | 3.65% |
2010 Q2 | 11.95 Billion JPY | 0.0% |
2009 FY | - JPY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Kitanotatsujin Corporation | 1.58 Billion JPY | -1359.594% |
Euglena Co., Ltd. | 676 Million JPY | -3328.55% |
BEAUTY GARAGE Inc. | 1.96 Billion JPY | -1079.593% |
Axas Holdings Co.,Ltd. | 555.75 Million JPY | -4070.34% |
C.I. Medical Co.,Ltd. | 4.01 Billion JPY | -477.548% |
Kao Corporation | 154.49 Billion JPY | 84.998% |
Niitaka Co., Ltd. | 1.36 Billion JPY | -1592.341% |
Rohto Pharmaceutical Co.,Ltd. | 48.85 Billion JPY | 52.559% |
Shiseido Company, Limited | 106.46 Billion JPY | 78.229% |
Lion Corporation | 42.31 Billion JPY | 45.226% |
Mandom Corporation | 6.69 Billion JPY | -245.977% |
Ivy Cosmetics Corporation | 242.6 Million JPY | -9453.586% |
Milbon Co., Ltd. | 7.8 Billion JPY | -197.125% |
Nippon Shikizai, Inc. | 1.28 Billion JPY | -1698.652% |
Fancl Corporation | 16.6 Billion JPY | -39.595% |
KOSÉ Corporation | 26.85 Billion JPY | 13.702% |
Cota Co., Ltd. | 2.26 Billion JPY | -921.703% |
HABA Laboratories,Inc. | -1.31 Billion JPY | 1863.435% |
C'bon Cosmetics Co.,Ltd. | 171.84 Million JPY | -13386.997% |
Noevir Holdings Co., Ltd. | 12.24 Billion JPY | -89.293% |
Adjuvant Holdings Co.,Ltd. | 124 Million JPY | -18591.129% |
Almado, Inc. | 983.21 Million JPY | -2257.26% |
I-ne CO., LTD. | 4.7 Billion JPY | -393.128% |
Premier Anti-Aging Co., Ltd. | -627 Million JPY | 3796.491% |
Liberta Co.,Ltd. | 318.19 Million JPY | -7183.967% |
AXXZIA Inc. | 1.28 Billion JPY | -1701.543% |
S.T. Corporation | 2.62 Billion JPY | -782.597% |
Kobayashi Pharmaceutical Co., Ltd. | 31.68 Billion JPY | 26.85% |
Earth Corporation | 10.6 Billion JPY | -118.486% |
Sagami Rubber Industries Co., Ltd. | 1.09 Billion JPY | -2017.499% |
Asahi Eito Holdings Co.,Ltd. | -573.98 Million JPY | 4137.939% |
Ya-Man Ltd. | 1.43 Billion JPY | -1513.131% |
MTG Co., Ltd. | 4.39 Billion JPY | -427.469% |
TRANSACTION CO.,Ltd. | 5.8 Billion JPY | -298.967% |
SHOBIDO Corporation | 1.11 Billion JPY | -1987.649% |
Artnature Inc. | 3.78 Billion JPY | -512.015% |
Pigeon Corporation | 15.8 Billion JPY | -46.634% |
Unicharm Corporation | 178.01 Billion JPY | 86.98% |
Paltac Corporation | 35.92 Billion JPY | 35.481% |
CB GROUP MANAGEMENT Co., Ltd. | 3.28 Billion JPY | -605.54% |